- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: low risk myelodysplastic syndromes, MDS, ASTX727
Total 38353 results
-
M.D. Anderson Cancer CenterRecruitingMyelodysplastic SyndromesUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingPolycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Myelodysplastic Syndrome | Clonal Cytopenia of Undetermined SignificanceUnited States
-
Bristol-Myers SquibbRecruitingMyelodysplastic SyndromesSpain, United States, France, Italy, Belgium, Germany, Poland, Czechia, Puerto Rico
-
Peking Union Medical College HospitalNot yet recruitingMyelodysplastic Syndromes
-
Institute of Hematology & Blood Diseases Hospital...Beijing Health Alliance Charitable FoundationRecruitingLower Risk MDS Per IPSS-RChina
-
Jasper Therapeutics, Inc.Recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbRecruitingMyelodysplastic Syndromes | Anemia | Myeloproliferative NeoplasmUnited States
-
Dongzhimen Hospital, BeijingNot yet recruiting
-
Forma Therapeutics, Inc.RecruitingVery Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-RUnited States, France, Canada, Germany
-
Technische Universität DresdenNot yet recruitingMyelodysplastic Syndromes
-
Tongji HospitalNot yet recruitingMyelodysplastic Syndromes
-
University of LeipzigCelgene CorporationRecruitingMyelodysplastic Syndromes | AnemiaGermany
-
M.D. Anderson Cancer CenterRecruitingMyelodysplastic Syndromes | Myeloproliferative Chronic Myelomonocytic LeukemiaUnited States
-
Rigel PharmaceuticalsRecruitingLow Risk Myelodysplastic SyndromesUnited States
-
GWT-TUD GmbHCelgeneRecruitingMyelodysplastic SyndromesAustria, Germany, Spain, Switzerland
-
Massachusetts General HospitalNovartisRecruiting
-
Novartis PharmaceuticalsRecruitingMyelodysplastic SyndromesJapan
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis PharmaceuticalsRecruitingMyelodysplastic SyndromesUnited States
-
Mikkael Sekeres, MDBristol-Myers Squibb; CelgeneRecruitingMyelodysplastic SyndromesUnited States
-
Keros Therapeutics, Inc.RecruitingMyelodysplastic Syndromes | CytopeniaAustralia, Spain, United States, Israel, France, Germany, New Zealand, Czechia
-
Josep Carreras Leukaemia Research InstituteCelgeneRecruitingMyelodysplastic SyndromesSpain
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); NovartisRecruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic SyndromeUnited States
-
Peking University People's HospitalRecruiting
-
University Hospital, GrenobleNovartisRecruiting
-
Groupe Francophone des MyelodysplasiesRecruitingMyelodysplastic SyndromesFrance
-
Mayo ClinicRecruitingHematologic Neoplasms | Myeloid Malignancy | Cytopenia | Bone Marrow Failure Syndrome | Clonal Cytopenia of Undetermined Significance | Clonal Hematopoiesis of Indeterminate Potential | Low Risk Myelodysplastic Syndrome | Inherited Bone Marrow Failure Syndrome | Clonal Expansion | Hereditary Neoplastic... and other conditionsUnited States
-
Children's Hospital Medical Center, CincinnatiMemorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer CenterRecruitingFanconi Anemia | Myelodysplastic Syndrome (MDS) | Acute Myelogenous Leukemia (AML) | Severe Marrow FailureUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPreviously Treated Myelodysplastic Syndrome | Myelodysplastic Syndrome | Aplastic Anemia | de Novo Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
Geron CorporationActive, not recruitingMyelodysplastic SyndromesUnited States, Canada, Belgium, Spain, Czechia, Korea, Republic of, United Kingdom, Netherlands, Israel, Germany, Russian Federation, Switzerland, Italy, France, Turkey, Poland, Ukraine
-
CelgeneAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Active, not recruitingMyelodysplastic SyndromesUnited States, Australia, Austria, Belgium, Canada, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Lithuania, Netherlands, Poland, Portugal, Russian Federation, Spain, Sweden, Switzerland, Taiwan, Turke... and more
-
Janssen Research & Development, LLCActive, not recruitingNeoplasms | Myelodysplastic Syndromes | Non-Hodgkin Lymphoma | Solid Tumor, AdultUnited States, Spain, Israel, Germany, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic SyndromeUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedMyelodysplastic Syndromes (MDS) | Acute Myelogenous Leukemia (AML)United States
-
Novartis PharmaceuticalsTerminatedMyelodysplastic SyndromesUnited States, Spain, Italy, Singapore, Korea, Republic of, Israel, Australia
-
University of LeipzigCuris, Inc.TerminatedMyelodysplastic Syndromes | AnemiaGermany
-
Agios Pharmaceuticals, Inc.Active, not recruitingMyelodysplastic SyndromesIsrael, United States, Korea, Republic of, Australia, France, Germany, Spain, United Kingdom, Czechia, Austria, Italy, Greece, Poland
-
Bristol-Myers SquibbActive, not recruitingMyelodysplastic SyndromesArgentina, Canada, France, Germany, Italy, Korea, Republic of, Poland, United States, Australia, China, Czechia, Denmark, Greece, Hong Kong, Japan, Spain, Sweden
-
University of LeipzigNovartis PharmaceuticalsTerminatedMyelodysplastic Syndromes | AnemiaGermany
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingLeukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic | Myelodysplastic SyndromeAustralia, United States, Canada, Spain, Belgium, France, Czechia, Italy, Korea, Republic of, Israel, Brazil, China, Germany, Turkey, Japan, Greece, Poland, United Kingdom, Russian Federation, Mexico
-
Rigshospitalet, DenmarkOdense University Hospital; University of Copenhagen; Imperial College London; University... and other collaboratorsActive, not recruitingMyelodysplastic Syndromes | Cytopenia | Chronic Myelomonocytic Leukemia-1Denmark, United States
-
Bristol-Myers SquibbActive, not recruitingLower-risk Myelodysplastic SyndromesJapan
-
FibroGenAstraZeneca; Astellas Pharma IncTerminatedPrimary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)United States, Australia, Belgium, Germany, Israel, Italy, Korea, Republic of, Russian Federation, Spain, United Kingdom, France, Turkey, Canada, Denmark, India, Poland
-
Groupe Francophone des MyelodysplasiesNovartis; Neovii BiotechActive, not recruiting
-
Gesellschaft fur Medizinische Innovation - Hamatologie...ClinAssess GmbHCompleted
-
Hemavant Sciences GmbHTerminatedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, ChronicKorea, Republic of, United States, Taiwan, Belgium, France, Spain, Italy
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingLeukemiaUnited States
-
CelgeneCompletedMyelodysplastic SyndromeUnited States, Australia, Canada, Czechia, France, Germany, Italy, Korea, Republic of, Mexico, Poland, Sweden, United Kingdom, Belgium, Brazil, Denmark, Finland, Greece, Israel, Netherlands, Norway, Portugal, Spain, Turkey
-
Syros PharmaceuticalsCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States, France
-
CelgeneCompletedLymphoma, Follicular | Myelodysplastic Syndromes | Lymphoma, Mantle-CellKorea, Republic of